The results indicated that EX-4 protects against myocardial hyperglycemia-induced apoptosis in a dose-dependent manner via a downregulation of caspase-3 cleavage; this effect was most significant at a 10-nM concentration of EX-4. This evidence concerns the gene CASP3 and Hyperglycemia.